Preparation and Characterization of Sulfanilamide-Loaded Patches for the Treatment of Acne
Abstract
: Acne vulgaris represents a chronic inflammation of the pilosebaceous apparatus, predominantly affecting the face and upper trunk due to the high concentration of sebaceous glands in these regions. Sulfanilamide is a sulfonamide antibacterial drug, a class of antibiotics that inhibit bacterial DNA synthesis by competitive antagonism of PABA. In this study, a novel patch formulation was developed for the effective treatment of acne using biocompatible polymers, hydroxypropyl methylcellulose (HPMC) and chitosan, as the matrix materials, and sulfanilamide as the active agent. The patches were prepared employing varying concentrations of chitosan (0.25%, 0.5%, and 1%), HPMC (0.125%, 0.25%, and 0.5%), and sulfanilamide (0.25%, 0.5%, and 0.75%) solutions. In this study, customized Design of Experiments (DoE) and response surface methodology (RSM) were applied to clarify the effect of the concentration of chitosan (X1), HPMC (X2), and sulfanilamide (X3) on swelling (Y1), porosity (Y2), and absorbency (Y3). Multi-response optimization analysis was conducted to identify the optimal formulation exhibiting maximum absorbency, minimum swelling, and appropriate porosity. The optimized patch formulation was subsequently characterized using Fourier transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM), in vitro drug release studies, and antibacterial activity studies. The findings revealed that the optimized formulation achieved controlled drug release along with notable antibacterial efficacy. Therefore, a controlled-release transdermal patch was successfully formulated for the effective treatment of acne.
Keywords
Project Number
References
- 1. Itoh T, Tsuchida A, Muramatsu Y, Ninomiya M, Ando M, Tsukamasa Y, et al. Antimicrobial and anti-inflammatory properties of nostocionone isolated from Nostoc commune Vauch and its derivatives against Propionibacterium acnes. Anaerobe. 2014 Jun;27:56–63. doi:
- 2. Oztürk A. Akne vulgaris’ in Psikiyatrik Etkileri [The psychiatric impact of acne vulgaris]. Kocatepe Med J. 2014;15(3):360–4.
- 3. Yamaner NJ. Akne vulgarisin topikal tedavisinde Tretinoin, Eritromisin ve Tretinoin+ Eritromisinin etkinliği. [Effectiveness of tretinoin, erythromycin and tretinoin + erythromycin in the topical treatment of acne vulgaris]. 2008.
- 4. Zaenglein AL. Acne Vulgaris. Solomon CG, editor. N Engl J Med. 2018 Oct 4;379(14):1343–52. doi:
- 5. Gungor E. Acne. Turk J Dermatol. 2012 Dec 1;6(4):138–49. doi:
- 6. Akhavan A, Bershad S. Topical Acne Drugs: Review of Clinical Properties, Systemic Exposure, and Safety. American Journal of Clinical Dermatology. 2003;4(7):473–92. doi:
- 7. Combes FC. SULFANILAMIDE AND ALLIED COMPOUNDS: THEIR VALUE AND LIMITATIONS IN DERMATOLOGY. Arch Derm Syphilol. 1941 Aug 1;44(2):236. doi:
- 8. Aranaz I, Acosta N, Civera C, Elorza B, Mingo J, Castro C, et al. Cosmetics and Cosmeceutical Applications of Chitin, Chitosan and Their Derivatives. Polymers. 2018 Feb 22;10(2):213. doi:
Details
Primary Language
English
Subjects
Medicinal and Biomolecular Chemistry (Other)
Journal Section
Research Article
Authors
Sema Arısoy
*
0000-0003-2798-1884
Türkiye
Meryem Koçaş
0000-0002-4165-6191
Türkiye
Nevin Tuzcu
0000-0001-5899-3955
Türkiye
Dilara Örgül
0000-0002-8947-4995
Türkiye
Tansel Çomoğlu
0000-0002-4221-5814
Türkiye
Publication Date
April 28, 2026
Submission Date
November 14, 2025
Acceptance Date
February 26, 2026
Published in Issue
Year 2026 Number: 2026-1
